APO Research
Talk to an analyst

APO RESEARCH · REPORT

Kasugamycin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Kasugamycin Industry Growth and Trends Forecast to 2032

20 December 2025108 pages

Choose your research edition.

Industry ResearchKasugamycin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Kasugamycin Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Kasugamycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Kasugamycin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Kasugamycin Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Kasugamycin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Kasugamycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Kasugamycin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Kasugamycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Kasugamycin include Hubei Saichuang, Hegno, Changzhou SYNchem, Anhui Royal Chemical, Zhejiang Rayfull Chemicals, SHALI CHEM & ART, King Quenson, Hokko Chemical and Fenchem, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Kasugamycin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Kasugamycin market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Kasugamycin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Kasugamycin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Kasugamycin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Kasugamycin Market by Company

Hubei Saichuang

Hegno

Changzhou SYNchem

Anhui Royal Chemical

Zhejiang Rayfull Chemicals

SHALI CHEM & ART

King Quenson

Hokko Chemical

Fenchem

Arysta Lifesciences

Kasugamycin Segment by Type

Kasugamycin 6%

Kasugamycin 4%

Kasugamycin 2%

Others

Kasugamycin Segment by Application

Melons and Fruits

Vegetables

Rice and Corns

Others

Kasugamycin Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kasugamycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Kasugamycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kasugamycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Kasugamycin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Kasugamycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Kasugamycin 6% Table 2. Major Company of Kasugamycin 4% Table 3. Major Company of Kasugamycin 2% Table 4. Major Company of Others Table 5. Global Kasugamycin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Kasugamycin Sales by Type (2021-2026) & (k tons) Table 7. Global Kasugamycin Sales Market Share in Volume by Type (2021-2026) Table 8. Global Kasugamycin Sales by Type (2021-2026) & (US$ Million) Table 9. Global Kasugamycin Sales Market Share in Value by Type (2021-2026) Table 10. Global Kasugamycin Price by Type (2021-2026) & (US$/ton) Table 11. Global Kasugamycin Sales by Type (2027-2032) & (k tons) Table 12. Global Kasugamycin Sales Market Share in Volume by Type (2027-2032) Table 13. Global Kasugamycin Sales by Type (2027-2032) & (US$ Million) Table 14. Global Kasugamycin Sales Market Share in Value by Type (2027-2032) Table 15. Global Kasugamycin Price by Type (2027-2032) & (US$/ton) Table 16. North America Kasugamycin Sales by Type (2021-2026) & (k tons) Table 17. North America Kasugamycin Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Kasugamycin Sales by Type (2021-2026) & (k tons) Table 19. Europe Kasugamycin Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Kasugamycin Sales by Type (2021-2026) & (k tons) Table 21. Asia-Pacific Kasugamycin Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Kasugamycin Sales by Type (2021-2026) & (k tons) Table 23. Latin America Kasugamycin Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Kasugamycin Sales by Type (2021-2026) & (k tons) Table 25. Middle East and Africa Kasugamycin Sales by Type (2021-2026) & (US$ Million) Table 26. Kasugamycin Industry Trends Table 27. Kasugamycin Industry Drivers Table 28. Kasugamycin Industry Opportunities and Challenges Table 29. Kasugamycin Industry Restraints Table 30. Global Kasugamycin Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Kasugamycin Revenue Market Share by Company (2021-2026) Table 32. Global Kasugamycin Sales by Company (2021-2026) & (k tons) Table 33. Global Kasugamycin Sales Share by Company (2021-2026) Table 34. Global Kasugamycin Market Price by Company (2021-2026) & (US$/ton) Table 35. Global Kasugamycin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Kasugamycin Major Company Production Sites and Headquarters Table 37. Global Kasugamycin Company, Product Type & Application Table 38. Global Kasugamycin Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Kasugamycin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Kasugamycin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Kasugamycin Sales by Region (2021-2026) & (k tons) Table 43. Global Kasugamycin Sales Market Share in Volume by Region (2021-2026) Table 44. Global Kasugamycin Sales by Region (2021-2026) & (US$ Million) Table 45. Global Kasugamycin Sales Market Share in Value by Region (2021-2026) Table 46. Global Kasugamycin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 47. Global Kasugamycin Sales by Region (2027-2032) & (k tons) Table 48. Global Kasugamycin Sales Market Share in Volume by Region (2027-2032) Table 49. Global Kasugamycin Sales by Region (2027-2032) & (US$ Million) Table 50. Global Kasugamycin Sales Market Share in Value by Region (2027-2032) Table 51. Global Kasugamycin Sales (k tons), Value (US$ Million), Price (US$/ton) and Gross Margin (2027-2032) Table 52. Global Kasugamycin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Kasugamycin Sales by Application (2021-2026) & (k tons) Table 54. Global Kasugamycin Sales Market Share in Volume by Application (2021-2026) Table 55. Global Kasugamycin Sales by Application (2021-2026) & (US$ Million) Table 56. Global Kasugamycin Sales Market Share in Value by Application (2021-2026) Table 57. Global Kasugamycin Price by Application (2021-2026) & (US$/ton) Table 58. Global Kasugamycin Sales by Application (2027-2032) & (k tons) Table 59. Global Kasugamycin Sales Market Share in Volume by Application (2027-2032) Table 60. Global Kasugamycin Sales by Application (2027-2032) & (US$ Million) Table 61. Global Kasugamycin Sales Market Share in Value by Application (2027-2032) Table 62. Global Kasugamycin Price by Application (2027-2032) & (US$/ton) Table 63. North America Kasugamycin Sales by Application (2021-2026) & (k tons) Table 64. North America Kasugamycin Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Kasugamycin Sales by Application (2021-2026) & (k tons) Table 66. Europe Kasugamycin Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Kasugamycin Sales by Application (2021-2026) & (k tons) Table 68. Asia-Pacific Kasugamycin Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Kasugamycin Sales by Application (2021-2026) & (k tons) Table 70. Latin America Kasugamycin Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Kasugamycin Sales by Application (2021-2026) & (k tons) Table 72. Middle East and Africa Kasugamycin Sales by Application (2021-2026) & (US$ Million) Table 73. Hubei Saichuang Company Information Table 74. Hubei Saichuang Business Overview Table 75. Hubei Saichuang Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 76. Hubei Saichuang Kasugamycin Product Portfolio Table 77. Hubei Saichuang Recent Development Table 78. Hegno Company Information Table 79. Hegno Business Overview Table 80. Hegno Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 81. Hegno Kasugamycin Product Portfolio Table 82. Hegno Recent Development Table 83. Changzhou SYNchem Company Information Table 84. Changzhou SYNchem Business Overview Table 85. Changzhou SYNchem Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 86. Changzhou SYNchem Kasugamycin Product Portfolio Table 87. Changzhou SYNchem Recent Development Table 88. Anhui Royal Chemical Company Information Table 89. Anhui Royal Chemical Business Overview Table 90. Anhui Royal Chemical Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 91. Anhui Royal Chemical Kasugamycin Product Portfolio Table 92. Anhui Royal Chemical Recent Development Table 93. Zhejiang Rayfull Chemicals Company Information Table 94. Zhejiang Rayfull Chemicals Business Overview Table 95. Zhejiang Rayfull Chemicals Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 96. Zhejiang Rayfull Chemicals Kasugamycin Product Portfolio Table 97. Zhejiang Rayfull Chemicals Recent Development Table 98. SHALI CHEM & ART Company Information Table 99. SHALI CHEM & ART Business Overview Table 100. SHALI CHEM & ART Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 101. SHALI CHEM & ART Kasugamycin Product Portfolio Table 102. SHALI CHEM & ART Recent Development Table 103. King Quenson Company Information Table 104. King Quenson Business Overview Table 105. King Quenson Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 106. King Quenson Kasugamycin Product Portfolio Table 107. King Quenson Recent Development Table 108. Hokko Chemical Company Information Table 109. Hokko Chemical Business Overview Table 110. Hokko Chemical Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 111. Hokko Chemical Kasugamycin Product Portfolio Table 112. Hokko Chemical Recent Development Table 113. Fenchem Company Information Table 114. Fenchem Business Overview Table 115. Fenchem Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 116. Fenchem Kasugamycin Product Portfolio Table 117. Fenchem Recent Development Table 118. Arysta Lifesciences Company Information Table 119. Arysta Lifesciences Business Overview Table 120. Arysta Lifesciences Kasugamycin Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 121. Arysta Lifesciences Kasugamycin Product Portfolio Table 122. Arysta Lifesciences Recent Development Table 123. North America Kasugamycin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 124. North America Kasugamycin Sales by Country (2021-2026) & (k tons) Table 125. North America Kasugamycin Sales Market Share by Country (2021-2026) Table 126. North America Kasugamycin Sales Forecast by Country (2027-2032) & (k tons) Table 127. North America Kasugamycin Sales Market Share Forecast by Country (2027-2032) Table 128. North America Kasugamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Kasugamycin Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Kasugamycin Market Share by Country (2021-2026) Table 131. North America Kasugamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Kasugamycin Market Share Forecast by Country (2027-2032) Table 133. Europe Kasugamycin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 134. Europe Kasugamycin Sales by Country (2021-2026) & (k tons) Table 135. Europe Kasugamycin Sales Market Share by Country (2021-2026) Table 136. Europe Kasugamycin Sales Forecast by Country (2027-2032) & (k tons) Table 137. Europe Kasugamycin Sales Market Share Forecast by Country (2027-2032) Table 138. Europe Kasugamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Europe Kasugamycin Market Size by Country (2021-2026) & (US$ Million) Table 140. Europe Kasugamycin Market Share by Country (2021-2026) Table 141. Europe Kasugamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Europe Kasugamycin Market Share Forecast by Country (2027-2032) Table 143. Asia-Pacific Kasugamycin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 144. Asia-Pacific Kasugamycin Sales by Country (2021-2026) & (k tons) Table 145. Asia-Pacific Kasugamycin Sales Market Share by Country (2021-2026) Table 146. Asia-Pacific Kasugamycin Sales Forecast by Country (2027-2032) & (k tons) Table 147. Asia-Pacific Kasugamycin Sales Market Share Forecast by Country (2027-2032) Table 148. Asia-Pacific Kasugamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Asia-Pacific Kasugamycin Market Size by Country (2021-2026) & (US$ Million) Table 150. Asia-Pacific Kasugamycin Market Share by Country (2021-2026) Table 151. Asia-Pacific Kasugamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Asia-Pacific Kasugamycin Market Share Forecast by Country (2027-2032) Table 153. Latin America Kasugamycin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 154. Latin America Kasugamycin Sales by Country (2021-2026) & (k tons) Table 155. Latin America Kasugamycin Sales Market Share by Country (2021-2026) Table 156. Latin America Kasugamycin Sales Forecast by Country (2027-2032) & (k tons) Table 157. Latin America Kasugamycin Sales Market Share Forecast by Country (2027-2032) Table 158. Latin America Kasugamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Latin America Kasugamycin Market Size by Country (2021-2026) & (US$ Million) Table 160. Latin America Kasugamycin Market Share by Country (2021-2026) Table 161. Latin America Kasugamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Latin America Kasugamycin Market Share Forecast by Country (2027-2032) Table 163. Middle East and Africa Kasugamycin Market Size Growth Rate (CAGR) by Country (k tons): 2021 VS 2025 VS 2032 Table 164. Middle East and Africa Kasugamycin Sales by Country (2021-2026) & (k tons) Table 165. Middle East and Africa Kasugamycin Sales Market Share by Country (2021-2026) Table 166. Middle East and Africa Kasugamycin Sales Forecast by Country (2027-2032) & (k tons) Table 167. Middle East and Africa Kasugamycin Sales Market Share Forecast by Country (2027-2032) Table 168. Middle East and Africa Kasugamycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East and Africa Kasugamycin Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East and Africa Kasugamycin Market Share by Country (2021-2026) Table 171. Middle East and Africa Kasugamycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East and Africa Kasugamycin Market Share Forecast by Country (2027-2032) Table 173. Key Raw Materials Table 174. Raw Materials Key Suppliers Table 175. Kasugamycin Distributors List Table 176. Kasugamycin Customers List Table 177. Research Programs/Design for This Report Table 178. Authors List of This Report Table 179. Secondary Sources Table 180. Primary Sources List of Figures Figure 1. Kasugamycin Image Figure 2. Global Kasugamycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Kasugamycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Kasugamycin Sales (2021-2032) & (k tons) Figure 5. Kasugamycin 6% Image Figure 6. Global Kasugamycin 6% Sales YoY Growth (2021-2032) & (k tons) Figure 7. Kasugamycin 4% Image Figure 8. Global Kasugamycin 4% Sales YoY Growth (2021-2032) & (k tons) Figure 9. Kasugamycin 2% Image Figure 10. Global Kasugamycin 2% Sales YoY Growth (2021-2032) & (k tons) Figure 11. Others Image Figure 12. Global Others Sales YoY Growth (2021-2032) & (k tons) Figure 13. Global Kasugamycin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Kasugamycin Market Share by Type 2025 VS 2032 Figure 15. North America Kasugamycin Sales Market Share in Volume by Type in 2025 Figure 16. North America Kasugamycin Sales Market Share in Value by Type in 2025 Figure 17. Europe Kasugamycin Sales Market Share in Volume by Type in 2025 Figure 18. Europe Kasugamycin Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Kasugamycin Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Kasugamycin Sales Market Share in Value by Type in 2025 Figure 21. Latin America Kasugamycin Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Kasugamycin Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Kasugamycin Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Kasugamycin Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Kasugamycin Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Melons and Fruits Image Figure 28. Global Melons and Fruits Sales YoY Growth (2021-2032) & (k tons) Figure 29. Vegetables Image Figure 30. Global Vegetables Sales YoY Growth (2021-2032) & (k tons) Figure 31. Rice and Corns Image Figure 32. Global Rice and Corns Sales YoY Growth (2021-2032) & (k tons) Figure 33. Others Image Figure 34. Global Others Sales YoY Growth (2021-2032) & (k tons) Figure 35. Global Kasugamycin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Kasugamycin Market Share by Application 2025 VS 2032 Figure 37. North America Kasugamycin Sales Market Share in Volume by Application in 2025 Figure 38. North America Kasugamycin Sales Market Share in Value by Application in 2025 Figure 39. Europe Kasugamycin Sales Market Share in Volume by Application in 2025 Figure 40. Europe Kasugamycin Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Kasugamycin Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Kasugamycin Sales Market Share in Value by Application in 2025 Figure 43. Latin America Kasugamycin Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Kasugamycin Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Kasugamycin Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Kasugamycin Sales Market Share in Value by Application in 2025 Figure 47. North America Kasugamycin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 48. North America Kasugamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Kasugamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Kasugamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Kasugamycin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 52. Europe Kasugamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Kasugamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Kasugamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Kasugamycin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 56. Asia-Pacific Kasugamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Kasugamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Kasugamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Kasugamycin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 60. Latin America Kasugamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Kasugamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Kasugamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Kasugamycin Sales by Country: 2021 VS 2025 VS 2032 (k tons) Figure 64. Middle East and Africa Kasugamycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Kasugamycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Kasugamycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Kasugamycin Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Kasugamycin Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Kasugamycin 6%
  • Kasugamycin 4%
  • Kasugamycin 2%
  • Others
Applications
  • Melons and Fruits
  • Vegetables
  • Rice and Corns
  • Others
Companies covered
  • Hubei Saichuang
  • Hegno
  • Changzhou SYNchem
  • Anhui Royal Chemical
  • Zhejiang Rayfull Chemicals
  • SHALI CHEM & ART
  • King Quenson
  • Hokko Chemical
  • Fenchem
  • Arysta Lifesciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Kasugamycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Kasugamycin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Kasugamycin Market by Type
  6. 1.3.1 Kasugamycin 6%
  7. 1.3.2 Kasugamycin 4%
  8. 1.3.3 Kasugamycin 2%
  9. 1.3.4 Others
  10. 1.4 Global Kasugamycin Market Size by Type
  11. 1.4.1 Global Kasugamycin Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Kasugamycin Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Kasugamycin Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Kasugamycin Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Kasugamycin Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Kasugamycin Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Kasugamycin Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Kasugamycin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Kasugamycin Industry Trends
  2. 2.2 Kasugamycin Industry Drivers
  3. 2.3 Kasugamycin Industry Opportunities and Challenges
  4. 2.4 Kasugamycin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Kasugamycin Revenue (2021-2026)
  2. 3.2 Global Top Players by Kasugamycin Sales (2021-2026)
  3. 3.3 Global Top Players by Kasugamycin Price (2021-2026)
  4. 3.4 Global Kasugamycin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Kasugamycin Major Company Production Sites & Headquarters
  6. 3.6 Global Kasugamycin Company, Product Type & Application
  7. 3.7 Global Kasugamycin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Kasugamycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Kasugamycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Kasugamycin Tier 1, Tier 2, and Tier 3
4 Kasugamycin Regional Status and Outlook
  1. 4.1 Global Kasugamycin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Kasugamycin Historic Market Size by Region
  3. 4.2.1 Global Kasugamycin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Kasugamycin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Kasugamycin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Kasugamycin Forecasted Market Size by Region
  7. 4.3.1 Global Kasugamycin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Kasugamycin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Kasugamycin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Kasugamycin by Application
  1. 5.1 Kasugamycin Market by Application
  2. 5.1.1 Melons and Fruits
  3. 5.1.2 Vegetables
  4. 5.1.3 Rice and Corns
  5. 5.1.4 Others
  6. 5.2 Global Kasugamycin Market Size by Application
  7. 5.2.1 Global Kasugamycin Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Kasugamycin Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Kasugamycin Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Kasugamycin Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Kasugamycin Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Kasugamycin Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Kasugamycin Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Kasugamycin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Hubei Saichuang
  2. 6.1.1 Hubei Saichuang Company Information
  3. 6.1.2 Hubei Saichuang Business Overview
  4. 6.1.3 Hubei Saichuang Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Hubei Saichuang Kasugamycin Product Portfolio
  6. 6.1.5 Hubei Saichuang Recent Developments
  7. 6.2 Hegno
  8. 6.2.1 Hegno Company Information
  9. 6.2.2 Hegno Business Overview
  10. 6.2.3 Hegno Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hegno Kasugamycin Product Portfolio
  12. 6.2.5 Hegno Recent Developments
  13. 6.3 Changzhou SYNchem
  14. 6.3.1 Changzhou SYNchem Company Information
  15. 6.3.2 Changzhou SYNchem Business Overview
  16. 6.3.3 Changzhou SYNchem Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Changzhou SYNchem Kasugamycin Product Portfolio
  18. 6.3.5 Changzhou SYNchem Recent Developments
  19. 6.4 Anhui Royal Chemical
  20. 6.4.1 Anhui Royal Chemical Company Information
  21. 6.4.2 Anhui Royal Chemical Business Overview
  22. 6.4.3 Anhui Royal Chemical Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Anhui Royal Chemical Kasugamycin Product Portfolio
  24. 6.4.5 Anhui Royal Chemical Recent Developments
  25. 6.5 Zhejiang Rayfull Chemicals
  26. 6.5.1 Zhejiang Rayfull Chemicals Company Information
  27. 6.5.2 Zhejiang Rayfull Chemicals Business Overview
  28. 6.5.3 Zhejiang Rayfull Chemicals Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Zhejiang Rayfull Chemicals Kasugamycin Product Portfolio
  30. 6.5.5 Zhejiang Rayfull Chemicals Recent Developments
  31. 6.6 SHALI CHEM & ART
  32. 6.6.1 SHALI CHEM & ART Company Information
  33. 6.6.2 SHALI CHEM & ART Business Overview
  34. 6.6.3 SHALI CHEM & ART Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 SHALI CHEM & ART Kasugamycin Product Portfolio
  36. 6.6.5 SHALI CHEM & ART Recent Developments
  37. 6.7 King Quenson
  38. 6.7.1 King Quenson Company Information
  39. 6.7.2 King Quenson Business Overview
  40. 6.7.3 King Quenson Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 King Quenson Kasugamycin Product Portfolio
  42. 6.7.5 King Quenson Recent Developments
  43. 6.8 Hokko Chemical
  44. 6.8.1 Hokko Chemical Company Information
  45. 6.8.2 Hokko Chemical Business Overview
  46. 6.8.3 Hokko Chemical Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Hokko Chemical Kasugamycin Product Portfolio
  48. 6.8.5 Hokko Chemical Recent Developments
  49. 6.9 Fenchem
  50. 6.9.1 Fenchem Company Information
  51. 6.9.2 Fenchem Business Overview
  52. 6.9.3 Fenchem Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Fenchem Kasugamycin Product Portfolio
  54. 6.9.5 Fenchem Recent Developments
  55. 6.10 Arysta Lifesciences
  56. 6.10.1 Arysta Lifesciences Company Information
  57. 6.10.2 Arysta Lifesciences Business Overview
  58. 6.10.3 Arysta Lifesciences Kasugamycin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Arysta Lifesciences Kasugamycin Product Portfolio
  60. 6.10.5 Arysta Lifesciences Recent Developments
7 North America by Country
  1. 7.1 North America Kasugamycin Sales by Country
  2. 7.1.1 North America Kasugamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Kasugamycin Sales by Country (2021-2026)
  4. 7.1.3 North America Kasugamycin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Kasugamycin Market Size by Country
  6. 7.2.1 North America Kasugamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Kasugamycin Market Size by Country (2021-2026)
  8. 7.2.3 North America Kasugamycin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Kasugamycin Sales by Country
  2. 8.1.1 Europe Kasugamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Kasugamycin Sales by Country (2021-2026)
  4. 8.1.3 Europe Kasugamycin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Kasugamycin Market Size by Country
  6. 8.2.1 Europe Kasugamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Kasugamycin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Kasugamycin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Kasugamycin Sales by Country
  2. 9.1.1 Asia-Pacific Kasugamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Kasugamycin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Kasugamycin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Kasugamycin Market Size by Country
  6. 9.2.1 Asia-Pacific Kasugamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Kasugamycin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Kasugamycin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Kasugamycin Sales by Country
  2. 10.1.1 South America Kasugamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Kasugamycin Sales by Country (2021-2026)
  4. 10.1.3 South America Kasugamycin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Kasugamycin Market Size by Country
  6. 10.2.1 South America Kasugamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Kasugamycin Market Size by Country (2021-2026)
  8. 10.2.3 South America Kasugamycin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Kasugamycin Sales by Country
  2. 11.1.1 Middle East and Africa Kasugamycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Kasugamycin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Kasugamycin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Kasugamycin Market Size by Country
  6. 11.2.1 Middle East and Africa Kasugamycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Kasugamycin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Kasugamycin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Kasugamycin Value Chain Analysis
  2. 12.1.1 Kasugamycin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Kasugamycin Production Mode & Process
  7. 12.2 Kasugamycin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Kasugamycin Distributors
  10. 12.2.3 Kasugamycin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst